Retatrutide
Each quantity unit = 1 research vial
Description
Retatrutide is a triple hormone receptor agonist targeting glp-1, gip, and glucagon receptors for research into metabolic regulation. Research applications include investigations into glucose homeostasis, weight management, appetite control, and metabolic syndrome in experimental models.
Regulatory Notice:
This product has not been evaluated by the Food and Drug Administration (FDA). It is not approved for human or veterinary use, diagnosis, treatment, cure, or prevention of any disease.
Important Research Note:
The information provided on this website is for research and educational purposes only. This information does not constitute medical advice, diagnosis, or treatment. Consult with qualified healthcare professionals for medical guidance.
Safety & Handling Disclaimer:
Products are sold "as is" without warranty. The buyer assumes all risk and liability for the results obtained by the use of any product. Use at your own risk.
